Abiochem Biotechnology Funding, Investors & Competitors

Abiochem Biotechnology has raised $109M across 2 funding rounds, most recently a $63M Series D in July 2025.

Last Abiochem Biotechnology funding round

$63M

Series D · Jul 2025

Cumulative funding Abiochem Biotechnology raised

$109M

across 2 funding rounds

Key investors in Abiochem Biotechnology

  • Temasek
  • CMB International Capital Corporation
  • SDIC Juli

Abiochem Biotechnology Overview

About Abiochem Biotechnology

Abiochem Biotechnology is a Shanghai-based high-tech firm specializing in enzyme and genetic engineering for biocatalysis. Applications span pharmaceutical intermediates, nutraceuticals, and pesticide synthesis using scalable synthetic biology processes. Established in 2012, the company promotes green chemistry through immobilized enzyme technologies.


Founded

2015

HQ

ChinaShanghai

Status

Privately held

Customer focus

B2B

Revenue model

Product sales

Abiochem Biotechnology Funding History

Abiochem Biotechnology has raised a total of $109M across 2 funding rounds.

Abiochem Biotechnology's first fundraising round was a $47M Series C in May 2021. The most recent completed round was a $63M Series D in July 2025.

Abiochem Biotechnology funding rounds

Abiochem Biotechnology funding rounds
DateStageInvestorsRaisedDeal Summary
Jul 2025Series DSDIC Juli (lead)$63MAbiochem Biotechnology (Group) Co., Ltd. is a leading domestic biomanufacturing enterprise with a comprehensive bioengineering resource library including enzymes, genetic elements, and chassis cells, along with synthetic biology technology innovation platforms. It specializes in biosynthesis, high-performance cell factory design, and scaled production, featuring a complete synthetic biology pathway from enzyme to biosynthetic pathway, smart cell, and product creation, supported by industrial manufacturing capabilities. The company offers a diverse product matrix, serving as a strategic partner to industry leaders in biopharmaceuticals, green agriculture, nutrition, and health, with first-approved functional ingredients in China such as HMOs (human milk oligosaccharides), steviol glycosides, and sialic acid. SDIC JULI completed a strategic investment of RMB 450 million in Abiochem, jointly made by the JULI M&A Fund and JULI Hangshi Fund. This investment aligns with SDIC Group’s strategic initiative in biomanufacturing, following their earlier investment in Moonsun Bio. Moving forward, SDIC JULI plans to collaborate with Abiochem on biomanufacturing innovation platforms, R&D centers, non-grain feedstock development, and fund investments to strengthen Abiochem’s leadership position and create sustainable economic and social value.
May 2021Series CCMB International Capital Corporation (lead); Temasek (lead)$47M-

Who has invested in Abiochem Biotechnology?

3 investors have backed Abiochem Biotechnology across its funding rounds, including Temasek, CMB International Capital Corporation and SDIC Juli.

Lead investors include SDIC Juli, CMB International Capital Corporation and Temasek.


Abiochem Biotechnology Investors

Investors in Abiochem Biotechnology by funding rounds participated
InvestorHQRoundsRoleFirst check
TemasekSingaporeSingapore1LeadMay 2021

This data is available for Pro users. Sign up to see all 3 Abiochem Biotechnology investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Abiochem Biotechnology Competitors

Abiochem Biotechnology competitors include listed companies like CF Industries, Qinghai Salt Lake Industry, Industries Qatar and SABIC Agri-Nutrient, and private ones like Colossal Biosciences and Biobest.

Public and private companies comparable to Abiochem Biotechnology
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
CF IndustriesUnited StatesUnited StatesPublicly listed$7.1B$3.2B$20B3.1x
Qinghai Salt Lake IndustryChinaChinaPublicly listed$2.3B$1.2B$20B4.5x
Industries QatarQatarQatarPublicly listed$4.4B$1.6B$17B4.4x
SABIC Agri-NutrientSaudi ArabiaSaudi ArabiaPublicly listed$3.5B$1.4B$16B4.1x
Colossal BiosciencesUnited StatesAustin, TXPrivate--$10B-
BiobestBelgiumWesterloPrivate--$1.5B-

Abiochem Biotechnology Public Comps

Abiochem Biotechnology is still privately-owned, but its public comps include CF Industries, Qinghai Salt Lake Industry, Industries Qatar, SABIC Agri-Nutrient, Zhejiang NHU, Fertiglobe, Cathay Biotech, PI Indus, K+S and Bloomage BioTechnology.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
CF Industries$7.1B$3.2B3.5x3.1x7.7x6.8x
Qinghai Salt Lake Industry$2.3B$1.2B6.9x4.5x13.3x7.3x
Industries Qatar$4.4B$1.6B3.4x4.4x9.5x14.1x
SABIC Agri-Nutrient$3.5B$1.4B3.8x4.1x9.5x10.1x
Zhejiang NHU$3.3B$1.5B3.5x3.1x7.6x6.7x
Fertiglobe$2.8B$1B2.5x2.1x6.9x5.8x
Cathay Biotech$491M$115M6.7x5.9x28.5x22.1x
PI Indus$695M$199M4.8x4.6x16.7x18.9x

This data is available for Pro users. Sign up to see all Abiochem Biotechnology competitors and their valuation data.

Start Free Trial

Common questions about Abiochem Biotechnology

When was Abiochem Biotechnology founded?Abiochem Biotechnology was founded in 2015.
Where is Abiochem Biotechnology headquartered?Abiochem Biotechnology is headquartered in Shanghai, China.
Is Abiochem Biotechnology publicly listed?No, Abiochem Biotechnology is a private, VC-backed company.
How much funding has Abiochem Biotechnology raised?Abiochem Biotechnology has raised $109M across 2 funding rounds.
What was Abiochem Biotechnology's last funding round?Abiochem Biotechnology's last funding round was a $63M Series D in July 2025, led by SDIC Juli.
Who are Abiochem Biotechnology's investors?Abiochem Biotechnology's investors include Temasek, SDIC Juli and CMB International Capital Corporation.
Which companies are comparable to Abiochem Biotechnology?Companies comparable to Abiochem Biotechnology include CF Industries, Qinghai Salt Lake Industry, Industries Qatar, SABIC Agri-Nutrient, Colossal Biosciences and Biobest.

See companies similar to Abiochem Biotechnology

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial